Online Simulation

And More

Top 25 Tags (all tags)

  1. algorithms
  2. aqme
  3. carbon nanotubes
  4. course lecture
  5. cyberinfrastructure
  6. devices
  7. education/outreach
  8. experiments
  9. material science
  10. molecular electronics
  11. nano/bio
  12. nanobio applications
  13. nano electro-mechanical systems
  14. nanoelectronics
  15. nanomedicine
  16. nanophotonics
  17. nano-transistors
  18. nanowires
  19. NEGF
  20. quantum dots
  21. quantum transport
  22. research seminar
  23. transistors
  24. tutorial
  25. uIllinois

Other

Trouble Report

For immediate assistance browse through our support center. You can find answers to many questions in just a few minutes.

If still experiencing problems, send us a report.

Sending report ...

BME 695N Engineering Nanomedical Systems

BME 695N Lecture 5: Cell Targeting

This resource has a 8.8 Ranking

Ranking is calculated from a formula comprised of user reviews and usage statistics. Learn more ›

Usage Stats
Last 12 Months: updated 01 Nov, 2008
Users: 246
Reviews & Citations
Google/IEEE
Avg. Review: 0.0 out of 5 stars
Citations: 0

246 users

0 reviews (Review this)

0 citations

View Presentation

Supporting Documents

Contributor(s) James Leary
Purdue University, West Lafayette
Abstract Outline:
  1. Overview: targeting nanosystems to cells
    1. Antibody targeting
    2. Peptide targeting
    3. Aptamer targeting
  2. Antibodies – polyclonal and monoclonal
    1. Where do antibodies come from – in nature?
    2. How do we make them in the laboratory?
    3. Monoclonal antibodies
    4. Therapy problems with mouse monoclonal antibodies
    5. “Humanizing” monoclonal antibodies to reduce adverse host immune reactions
    6. Why antibodies may not be a good overall choices for targeting nanosystems to cells
  3. Peptide targeting
    1. How does a peptide target?
    2. Examples of peptide targeting
    3. Creating new peptides by random peptide phage display libraries
    4. High-throughput screening of those peptide libraries
    5. Advantages and disadvantages of peptide targeting
  4. Aptamer targeting
    1. What are aptamers and how do they target?
    2. Some different types of aptamers
    3. How do you make aptamers?
    4. How do you screen for useful aptamers?
References
Cite this work

If you reference this work in a publication, please cite as follows:

  • Leary, James (2007), "BME 695N Lecture 5: Cell Targeting," http://www.nanohub.org/resources/3176/.

    BibTex | EndNote

Date posted 12 Sep, 2007
Time 04:30 PM, September 04, 2007
Location Biomedical Engineering Building, Room 1083
Type Online Presentations
Tags

Citations

The following are publications that have cited this resource, separated by their affiliation to the NCN.

No citations found.

Reviews

The following are reviews of this resource from other site members.

Write a review

No reviews found. Be the first to review this resource!

See also

The following are resources that may cover similar or related topics.

  • 8.9 Ranking Courses Part of: BME 695N Engineering Nanomedical Systems

    BME 695N Engineering Nanomedical Systems

    Type Courses
    Contributor(s) James Leary
    Date 28 Aug, 2007
    Avg. Rating 5.0 out of 5 stars  (1)
    Rate this

    This course will cover the basic concepts of design of integrated nanomedical systems for diagnostics and therapeutics. Topics to be covered include: why nanomedical approaches are needed, cell targeting strategies, choice of core nanomaterials, technologies for testing composition and structure …

People who looked at this also looked at:

Network Recommendations powered by CIKNOW developed by the Science of Networks in Communities Research (SONIC) group at Northwestern University.

Recommendations will load momentarily. If you do not see content change after 30 seconds, there may be a number of reasons:

  • You have javascript turned off in your browser.
  • You have browser incapable of handling the scripts that load the recommendations.
  • There is a problem with the recommendation service and it failed to respond.